Correlation Between Equillium and ABVC Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Equillium and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and ABVC Biopharma, you can compare the effects of market volatilities on Equillium and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and ABVC Biopharma.

Diversification Opportunities for Equillium and ABVC Biopharma

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Equillium and ABVC is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Equillium i.e., Equillium and ABVC Biopharma go up and down completely randomly.

Pair Corralation between Equillium and ABVC Biopharma

Allowing for the 90-day total investment horizon Equillium is expected to generate 1.39 times more return on investment than ABVC Biopharma. However, Equillium is 1.39 times more volatile than ABVC Biopharma. It trades about -0.03 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.1 per unit of risk. If you would invest  75.00  in Equillium on September 12, 2024 and sell it today you would lose (5.00) from holding Equillium or give up 6.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Equillium  vs.  ABVC Biopharma

 Performance 
       Timeline  
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
ABVC Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Equillium and ABVC Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Equillium and ABVC Biopharma

The main advantage of trading using opposite Equillium and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.
The idea behind Equillium and ABVC Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stocks Directory
Find actively traded stocks across global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum